Share
News
-
27 November 2009 /Side effects and trials
Side effects from Pandemrix® from 17 to 20 November 2009
In the period from 17 to 20 November, the Danish Medicines Agency received 87 new side effect reports covering a total of 310 suspected side effects (adverse reactions).
-
23 November 2009 /Side effects and trials
EMEA: H1N1 vaccine is safe and efficient
The European Medicines Agency (EMEA) has issued a press release stating that a new review of data on Pandemrix® and other vaccines against H1N1 shows that it is sufficient to use a single dose of vaccine for adults, elderly people and children aged 10 and older.
-
23 November 2009 /Side effects and trials
European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents
The European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of neophrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of developing the condition.
-
23 November 2009 /Side effects and trials
Gadolinium and nephrogenic systemic fibrosis: New recommendations from the European Medicines Agency
The European Medicines Agency (EMEA) has adopted new recommendations for the use of gadolinium-containing contrast agents to minimise the risk of a rare adverese reaction, neophrogenic systemic fibrosis (NSF)
-
23 November 2009 /Retail and online sale
Global operation against illegal medicines takes down more than 70 websites
A global operation against illegal medicine has taken down more than 70 illegal websites,and a total of 22 individuals are currently under investigation for a range of offenses.
-
20 November 2009 /Side effects and trials
Side effects from Pandemrix® from 11 to 16 November 2009
In the period of 11 - 16 November, the Danish Medicines Agency received 73 new side effect reports related to the Pandemrix® vaccine against influenza.
-
23 November 2009 | Updated 19 November 2009 /Side effects and trials
Tamiflu® for prevention and treatment during an influenza epidemic
Earlier this year, the European Medicines Agency updated the product information for Tamiflu® to ensure that as many people as possible can benefit from the medicine in connection with an influenza epidemic.
-
12 November 2009 /Side effects and trials
Side effects from Pandemrix® from 4 to 10 November 2009
The Danish Medicines Agency has received the first side effect reports related to the Pandemrix® vaccine against influenza.
-
10 November 2009 /Authorisation and supervision
Information about variation applications from 1 January 2010
In a new regulation, the European Commission has established new rules that regulate variations of authorisations granted according to the Centralised Procedure, Decentralised Procedure (DCP) and the Mutual Recognition Procedure (MRP).
-
06 November 2009 /News - miscellaneous
The Danish Medicines Agency and the Danish Veterinary and Food Administration complete joint control of five sports stores
The Danish Medicines Agency and the Danish Veterinary and Food Administration complete joint control og five sports stores.
-
05 November 2009 /Side effects and trials
Problem regarding receipt of adverse reaction reports now solved
Yesterday and the day before, the Danish Medicines Agency had problems receiving ICSRs and SUSARs via the EudraVigilance gateway, due to an error that occurred in the update of the message format release version.
